This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kite Pharma, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jodi Murakami: Innovator in Chimeric Antigen Receptor Technology
Introduction
Jodi Murakami is a prominent inventor based in Culver City, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs). Her innovative work has the potential to revolutionize cancer treatment and cell therapies.
Latest Patents
Jodi holds a patent for a chimeric antigen receptor that comprises an NGK2D ecto domain. This patent includes compositions, cells, and cell therapies that utilize these CARs, along with methods of treatment. Her groundbreaking work in this area has garnered attention for its potential applications in immunotherapy.
Career Highlights
Jodi is currently employed at Kite Pharma, Inc., a leading company in the field of cell therapy. Her role at Kite Pharma allows her to work on cutting-edge research and development projects that aim to improve patient outcomes in cancer treatment. With her expertise, she has become a valuable asset to the team.
Collaborations
Jodi collaborates with notable colleagues, including Samuel T. Haile and Kevin P. Meng. Together, they work on advancing the science of CAR technology and its applications in therapeutic settings.
Conclusion
Jodi Murakami's contributions to the field of chimeric antigen receptors exemplify her dedication to innovation in biotechnology. Her work at Kite Pharma, along with her patent, positions her as a key figure in the ongoing development of effective cancer therapies.